|
|
Volumn 17, Issue 4, 2008, Pages 445-455
|
|
Sustained analgesic peptide secretion and cell labeling using a novel genetic modification
|
|
Author keywords
Histogranin; Lentiviral; NMDA antagonist; Pain; PC12 cells; Transplantation
|
|
Indexed keywords
ANALGESIC AGENT;
CATHEPSIN L;
CYCLOSPORIN A;
LENTIVIRUS VECTOR;
N METHYL DEXTRO ASPARTIC ACID;
NERVE GROWTH FACTOR BETA SUBUNIT;
RED FLUORESCENT PROTEIN;
SERYLHISTOGRANIN;
SIGNAL PEPTIDASE;
AMINO TERMINAL SEQUENCE;
ANALGESIA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CELL BASED GENE THERAPY;
CELL LABELING;
CELL STRAIN;
CELL THERAPY;
CEREBROSPINAL FLUID;
CONFERENCE PAPER;
CONFOCAL MICROSCOPY;
CONTROLLED STUDY;
DNA MODIFICATION;
DOT HYBRIDIZATION;
GENETIC ENGINEERING;
HUMAN;
HUMAN CELL;
IMMUNOCYTOCHEMISTRY;
NEUROPATHIC PAIN;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN SECRETION;
RAT;
WESTERN BLOTTING;
RODENTIA;
|
|
EID: 44149115476
PISSN: 09636897
EISSN: None
Source Type: Journal
DOI: 10.3727/096368908784423265 Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (45)
|
